MYCN-amplified neuroblastoma (MNA neuroblastoma) represents about half of poor prognosis neuroblastoma, with the remainder attributable to enhancer alterations leading to over-expression of TERT [3] or MYC [4]. The gene discussed is TERT; the disease is neuroblastoma.